PriceTargets.com logo

Heart Test Laboratories - HSCS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $15.00
  • Forecasted Upside: 289.61%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.85 As of 12/17/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for HSCS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Heart Test Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HSCS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HSCS

Analyst Price Target is $15.00
▲ +289.61% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Heart Test Laboratories in the last 3 months. The average price target is $15.00, with a high forecast of $15.00 and a low forecast of $15.00. The average price target represents a 289.61% upside from the last price of $3.85.

This chart shows the closing price for HSCS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Heart Test Laboratories.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/18/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/17/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/23/2024Ascendiant Capital MarketsReiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
1/30/2023Ascendiant Capital MarketsInitiated CoverageBuy$330.00
12/19/2022Maxim GroupLower TargetBuy$800.00 ➝ $300.00
11/9/2022Maxim GroupInitiated CoverageBuy$800.00
8/8/2022BenchmarkInitiated CoverageSpeculative Buy$800.00
(Data available from 12/18/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/22/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/19/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Heart Test Laboratories logo
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Read More

Today's Range

Now: $3.85
Low: $3.41
High: $3.98

50 Day Range

MA: $3.25
Low: $2.59
High: $4.47

52 Week Range

Now: $3.85
Low: $2.36
High: $18.50

Volume

15,719 shs

Average Volume

131,441 shs

Market Capitalization

$3.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.23

Frequently Asked Questions

What sell-side analysts currently cover shares of Heart Test Laboratories?

The following Wall Street research analysts have issued stock ratings on Heart Test Laboratories in the last year: Ascendiant Capital Markets.
View the latest analyst ratings for HSCS.

What is the current price target for Heart Test Laboratories?

0 Wall Street analysts have set twelve-month price targets for Heart Test Laboratories in the last year. Their average twelve-month price target is $15.00, suggesting a possible upside of 289.6%. Ascendiant Capital Markets has the highest price target set, predicting HSCS will reach $15.00 in the next twelve months. Ascendiant Capital Markets has the lowest price target set, forecasting a price of $15.00 for Heart Test Laboratories in the next year.
View the latest price targets for HSCS.

What is the current consensus analyst rating for Heart Test Laboratories?

Heart Test Laboratories currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HSCS will outperform the market and that investors should add to their positions of Heart Test Laboratories.
View the latest ratings for HSCS.

What other companies compete with Heart Test Laboratories?

Other companies that are similar to Heart Test Laboratories include STRATA Skin Sciences, Meihua International Medical Technologies, Lyra Therapeutics, PolyPid and QT Imaging. Learn More about companies similar to Heart Test Laboratories.

How do I contact Heart Test Laboratories' investor relations team?

The company's listed phone number is 682-237-7781 and its investor relations email address is [email protected]. The official website for Heart Test Laboratories is heartsciences.com. Learn More about contacing Heart Test Laboratories investor relations.